4.7 Review

Nectin 4 is the epithelial cell receptor for measles virus

期刊

TRENDS IN MICROBIOLOGY
卷 20, 期 9, 页码 429-439

出版社

CELL PRESS
DOI: 10.1016/j.tim.2012.05.006

关键词

measles; epithelial receptor; adenocarcinoma; oncolytic virus; Nectin 4; PVRL4; virus release; adherens junctions

资金

  1. Canadian Institutes of Health Operating Grant [CIHR MOP 10638]
  2. Nova Scotia Health Research Foundation Health Research Grant [1200]
  3. Canadian Breast Cancer Foundation Atlantic Region Grant [2189]
  4. National Cancer Institute of Canada and Terry Fox Foundation Grant [16340]
  5. Nova Scotia Health Research Foundation
  6. Terry Fox Foundation Strategic Health Research Training Program in Cancer Research at CIHR
  7. Canadian Foundation for Innovation

向作者/读者索取更多资源

Measles virus (MV) causes acute respiratory disease, infects lymphocytes and multiple organs, and produces immune suppression leading to secondary infections. In rare instances it can also cause persistent infections in the brain and central nervous system. Vaccine and laboratory-adapted strains of MV use CD46 as a receptor, whereas wild-type strains of MV (wtMV) cannot. Both vaccine and wtMV strains infect lymphocytes, monocytes, and dendritic cells (DCs) using the signaling lymphocyte activation molecule (CD150/SLAM). In addition, MV can infect the airway epithelial cells of the host. Nectin 4 (PVRL4) was recently identified as the epithelial cell receptor for MV. Coupled with recent observations made in MV-infected macaques, this discovery has led to a new paradigm for how the virus accesses the respiratory tract and exits the host. Nectin 4 is also a tumor cell marker which is highly expressed on the apical surface of many adenocarcinoma cell lines, making it a potential target for MV oncolytic therapy.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据